Literature DB >> 403138

Evaluation of experimentally induced Fusobacterium necrophorum infections in mice.

P J Conlon, K P Hepper, G W Teresa.   

Abstract

Two strains of mice, Swiss Webster and DBA/2Cr, were injected intraperitoneally or intravenously with varying dosages of Fusobacterium necrophorum. The ability to eliminate the infection was assessed by quantitative enumeration of the organisms present in the blood, liver, and spleen, Three- to 4-week-old DBA/2Cr mice were highly resistant to both routes of injection. The intraperitoneal injection of older mice failed to demonstrate a dose-effect relationship whereas an intravenous injection of as few as 10(4) cells of F. necrophorum produced progressively necrotic leg abscesses, apparently involving the lymphonodus ischiadicus which filters the site of injection. Mortality was increased with sensitization by a previous sublethal injection. Also, an ethanol-killed cell vaccine delayed the onset of lethal infection, whereas repeated sublethal live cell injections provided nonspecific protection since mice vaccinated with the growth medium were equally protected. The development of leg abscesses after intravenous injection visibly demonstrated the pathogenicity of F. necrophorum and may provide a suitable model for the evaluation of vaccines and the effectiveness of antibiotics.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403138      PMCID: PMC421397          DOI: 10.1128/iai.15.2.510-517.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  BASIS FOR IMMUNITY TO TYPHOID IN MICE AND THE QUESTION OF "CELLULAR IMMUNITY".

Authors:  C R JENKIN; D ROWLEY
Journal:  Bacteriol Rev       Date:  1963-12

2.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

3.  MECHANISMS OF ENDOTOXIN TOLERANCE. 3. THE REFRACTORY STATE DURING CONTINUOUS INTRAVENOUS INFUSIONS OF ENDOTOXIN.

Authors:  S E GREISMAN; W E WOODWARD
Journal:  J Exp Med       Date:  1965-06-01       Impact factor: 14.307

4.  The rumenitis-liver abscess complex in beef cattle.

Authors:  R JENSEN; H M DEANE; L J COOPER; V A MILLER; W R GRAHAM
Journal:  Am J Vet Res       Date:  1954-04       Impact factor: 1.156

5.  Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice.

Authors:  T D Wilkins; L D Smith
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

6.  Experimental hepatic necrobacillosis in beef cattle.

Authors:  R JENSEN; J C FLINT; L A GRINER
Journal:  Am J Vet Res       Date:  1954-01       Impact factor: 1.156

7.  Bacteroides infections.

Authors:  L V McVAY; D H SPRUNT
Journal:  Ann Intern Med       Date:  1952-01       Impact factor: 25.391

Review 8.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

9.  Macrophage activation in mice infected with ectromelia or lymphocytic choriomeningitis viruses.

Authors:  R V Blanden; C A Mims
Journal:  Aust J Exp Biol Med Sci       Date:  1973-06

10.  Mechanisms of acquired resistance in mouse typhoid.

Authors:  R V Blanden; G B Mackaness; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Fusobacterium necrophorum infections: virulence factors, pathogenic mechanism and control measures.

Authors:  Z L Tan; T G Nagaraja; M M Chengappa
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

2.  Identification of three immunodominant regions on leukotoxin protein of Fusobacterium necrophorum.

Authors:  D B Sun; R Wu; G L Li; J S Zheng; X P Liu; Y C Lin; D H Guo
Journal:  Vet Res Commun       Date:  2009-05-16       Impact factor: 2.459

3.  Anaerobic orbital cellulitis: a clinical and experimental study.

Authors:  M S Jedrzynski; J D Bullock; T W McGuire; B L Elder; J D Bullock
Journal:  Trans Am Ophthalmol Soc       Date:  1991
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.